380 related articles for article (PubMed ID: 33676569)
41. A chemical probe toolbox for dissecting the cancer epigenome.
Shortt J; Ott CJ; Johnstone RW; Bradner JE
Nat Rev Cancer; 2017 Feb; 17(3):160-183. PubMed ID: 28228643
[TBL] [Abstract][Full Text] [Related]
42. EZH2 regulates sFRP4 expression without affecting the methylation of sFRP4 promoter DNA in colorectal cancer cell lines.
Liu Y; Yu J; Xie Y; Li M; Wang F; Zhang J; Qi J
Exp Ther Med; 2020 Nov; 20(5):33. PubMed ID: 32952624
[TBL] [Abstract][Full Text] [Related]
43. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
[TBL] [Abstract][Full Text] [Related]
44. Crosstalk between histone modification and DNA methylation orchestrates the epigenetic regulation of the costimulatory factors, Tim‑3 and galectin‑9, in cervical cancer.
Zhang L; Tian S; Pei M; Zhao M; Wang L; Jiang Y; Yang T; Zhao J; Song L; Yang X
Oncol Rep; 2019 Dec; 42(6):2655-2669. PubMed ID: 31661141
[TBL] [Abstract][Full Text] [Related]
45. Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylation.
Roll JD; Rivenbark AG; Sandhu R; Parker JS; Jones WD; Carey LA; Livasy CA; Coleman WB
Exp Mol Pathol; 2013 Dec; 95(3):276-87. PubMed ID: 24045095
[TBL] [Abstract][Full Text] [Related]
46. DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation.
Milutinovic S; Brown SE; Zhuang Q; Szyf M
J Biol Chem; 2004 Jul; 279(27):27915-27. PubMed ID: 15087453
[TBL] [Abstract][Full Text] [Related]
47. Cooperation between EZH2, NSPc1-mediated histone H2A ubiquitination and Dnmt1 in HOX gene silencing.
Wu X; Gong Y; Yue J; Qiang B; Yuan J; Peng X
Nucleic Acids Res; 2008 Jun; 36(11):3590-9. PubMed ID: 18460542
[TBL] [Abstract][Full Text] [Related]
48. A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis.
Coward WR; Feghali-Bostwick CA; Jenkins G; Knox AJ; Pang L
FASEB J; 2014 Jul; 28(7):3183-96. PubMed ID: 24652950
[TBL] [Abstract][Full Text] [Related]
49. The downregulation of GFI1 by the EZH2-NDY1/KDM2B-JARID2 axis and by human cytomegalovirus (HCMV) associated factors allows the activation of the HCMV major IE promoter and the transition to productive infection.
Sourvinos G; Morou A; Sanidas I; Codruta I; Ezell SA; Doxaki C; Kampranis SC; Kottakis F; Tsichlis PN
PLoS Pathog; 2014 May; 10(5):e1004136. PubMed ID: 24830456
[TBL] [Abstract][Full Text] [Related]
50. Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets.
Chekhun VF; Lukyanova NY; Kovalchuk O; Tryndyak VP; Pogribny IP
Mol Cancer Ther; 2007 Mar; 6(3):1089-98. PubMed ID: 17363502
[TBL] [Abstract][Full Text] [Related]
51. Increased copy number of imprinted genes in the chromosomal region 20q11-q13.32 is associated with resistance to antitumor agents in cancer cell lines.
Krushkal J; Vural S; Jensen TL; Wright G; Zhao Y
Clin Epigenetics; 2022 Dec; 14(1):161. PubMed ID: 36461044
[TBL] [Abstract][Full Text] [Related]
52. Glyphosate and AMPA Induce Alterations in Expression of Genes Involved in Chromatin Architecture in Human Peripheral Blood Mononuclear Cells (In Vitro).
Woźniak E; Reszka E; Jabłońska E; Michałowicz J; Huras B; Bukowska B
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803994
[TBL] [Abstract][Full Text] [Related]
53. Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells.
Sun F; Chan E; Wu Z; Yang X; Marquez VE; Yu Q
Mol Cancer Ther; 2009 Dec; 8(12):3191-202. PubMed ID: 19934278
[TBL] [Abstract][Full Text] [Related]
54. SIRT1 affects DNA methylation of polycomb group protein target genes, a hotspot of the epigenetic shift observed in ageing.
Wakeling LA; Ions LJ; Escolme SM; Cockell SJ; Su T; Dey M; Hampton EV; Jenkins G; Wainwright LJ; McKay JA; Ford D
Hum Genomics; 2015 Jun; 9(1):14. PubMed ID: 26104761
[TBL] [Abstract][Full Text] [Related]
55. Regulation of the expression of claudin 23 by the enhancer of zeste 2 polycomb group protein in colorectal cancer.
Maryan N; Statkiewicz M; Mikula M; Goryca K; Paziewska A; Strzałkowska A; Dabrowska M; Bujko M; Ostrowski J
Mol Med Rep; 2015 Jul; 12(1):728-36. PubMed ID: 25695204
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of microRNA let-7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer.
Kuang Y; Xu H; Lu F; Meng J; Yi Y; Yang H; Hou H; Wei H; Su S
Cancer Sci; 2021 Jan; 112(1):231-242. PubMed ID: 33091189
[TBL] [Abstract][Full Text] [Related]
57. Anxiety is associated with higher levels of global DNA methylation and altered expression of epigenetic and interleukin-6 genes.
Murphy TM; O'Donovan A; Mullins N; O'Farrelly C; McCann A; Malone K
Psychiatr Genet; 2015 Apr; 25(2):71-8. PubMed ID: 25350786
[TBL] [Abstract][Full Text] [Related]
58. Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens.
Schirmer U; Fiegl H; Pfeifer M; Zeimet AG; Müller-Holzner E; Bode PK; Tischler V; Altevogt P
BMC Cancer; 2013 Mar; 13():156. PubMed ID: 23530769
[TBL] [Abstract][Full Text] [Related]
59. Histone Methyltransferase Enhancer of Zeste Homolog 2-Mediated ABCA1 Promoter DNA Methylation Contributes to the Progression of Atherosclerosis.
Lv YC; Tang YY; Zhang P; Wan W; Yao F; He PP; Xie W; Mo ZC; Shi JF; Wu JF; Peng J; Liu D; Cayabyab FS; Zheng XL; Tang XY; Ouyang XP; Tang CK
PLoS One; 2016; 11(6):e0157265. PubMed ID: 27295295
[TBL] [Abstract][Full Text] [Related]
60. Reversing aberrant methylation patterns in cancer.
Poke FS; Qadi A; Holloway AF
Curr Med Chem; 2010; 17(13):1246-54. PubMed ID: 20166939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]